Advertisement

Digestive Diseases and Sciences

, Volume 60, Issue 10, pp 3085–3091 | Cite as

Vitamin D Deficiency Associated with Disease Activity in Patients with Inflammatory Bowel Diseases

  • Mehdi Torki
  • Ali GholamrezaeiEmail author
  • Leila Mirbagher
  • Manijeh Danesh
  • Sara Kheiri
  • Mohammad Hassan Emami
Original Article

Abstract

Background

Evidence exists on the association between vitamin D deficiency and inflammatory bowel diseases (IBD).

Aims

To investigate whether vitamin D level is associated with disease activity and quality of life in IBD patients.

Methods

This cross-sectional study was conducted on known adult IBD patients referred to an outpatient clinic of gastroenterology in Isfahan city, Iran. Disease activity was evaluated using the Simplified Crohn’s Disease Activity Index and Simple Clinical Colitis Activity Index. Quality of life was assessed with the Short-Inflammatory Bowel Disease Questionnaire. Serum 25[OH]D was measured using the radioimmunoassay method. Vitamin D deficiency and insufficiency were defined as concentration of <50 and 50–75 nmol/L, respectively.

Results

Studied subjects were 85 ulcerative colitis and 48 Crohn’s disease patients (54.1 % females) with mean age of 42.0 ± 14.0 years. Vitamin D deficiency and insufficiency were present in 52 (39.0 %) and 24 (18.0 %) patients, respectively. Thirty patients (22.5 %) had active disease who, compared with patients in remission, had more frequent low vitamin D levels (80 vs. 50.4 %, P = 0.005). Quality of life was not different between patients with low and those with normal vitamin D levels (P = 0.693). In the logistic regression model, low vitamin D was independently associated with active disease status, OR (95 % CI) = 5.959 (1.695–20.952).

Conclusions

We found an association between vitamin D deficiency/insufficiency and disease activity in IBD patients. Prospective cohorts and clinical trials are required to clarify the role of vitamin D deficiency and its treatment in clinical course of IBD.

Keywords

Vitamin D 25-Hydroxyvitamin D Inflammatory bowel diseases Ulcerative colitis Crohn’s disease Quality of life 

Notes

Acknowledgments

This study was supported by the Isfahan University of Medical Sciences. The sponsor had no role in the study design, the collection, analysis and interpretation of data, writing of the manuscript, or the decision to submit the manuscript for publication. Author’s contributions were as follows: AGh and MHE participated in study conception and design. MT prepared the grant proposal. All authors participated in data collection and primary analysis. AGh performed statistical analysis. MT, AGh, and MHE participated in data analysis interpretation. MT, AGh, and LM prepared the manuscript draft. All authors studied, revised, and approved the final version of manuscript.

Conflicts of interest

There is no conflict of interest.

References

  1. 1.
    Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis. 2006;12:S3–S9.CrossRefPubMedGoogle Scholar
  2. 2.
    Aghazadeh R, Zali MR, Bahari A, Amin K, Ghahghaie F, Firouzi F. Inflammatory bowel disease in Iran: a review of 457 cases. J Gastroenterol Hepatol. 2005;20:1691–1695.CrossRefPubMedGoogle Scholar
  3. 3.
    Ananthakrishnan AN. Environmental risk factors for inflammatory bowel diseases: a review. Dig Dis Sci. 2015;60:290–298.CrossRefPubMedGoogle Scholar
  4. 4.
    Lim WC, Hanauer SB, Li YC. Mechanisms of disease: vitamin D and inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol. 2005;2:308–315.CrossRefPubMedGoogle Scholar
  5. 5.
    Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol. 2008;8:685–698.PubMedCentralCrossRefPubMedGoogle Scholar
  6. 6.
    Garland CF, Garland FC, Gorham ED, et al. The role of vitamin D in cancer prevention. Am J Public Health. 2006;96:252–261.PubMedCentralCrossRefPubMedGoogle Scholar
  7. 7.
    Munger KL, Zhang SM, O’Reilly E, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology. 2004;62:60–65.CrossRefPubMedGoogle Scholar
  8. 8.
    Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev. 2006;5:114–117.CrossRefPubMedGoogle Scholar
  9. 9.
    Mouli VP, Ananthakrishnan AN. Review article: vitamin D and inflammatory bowel diseases. Aliment Pharmacol Ther. 2014;39:125–136.CrossRefPubMedGoogle Scholar
  10. 10.
    Ananthakrishnan AN, Cheng SC, Cai T, et al. Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2014;12:821–827.PubMedCentralCrossRefPubMedGoogle Scholar
  11. 11.
    Cantorna MT, McDaniel K, Bora S, Chen J, James J. Vitamin D, immune regulation, the microbiota, and inflammatory bowel disease. Exp Biol Med (Maywood). 2014;239:1524–1530.CrossRefGoogle Scholar
  12. 12.
    Kong J, Zhang Z, Musch MW, et al. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol. 2008;294:G208–G216.CrossRefPubMedGoogle Scholar
  13. 13.
    Assa A, Vong L, Pinnell LJ, Avitzur N, Johnson-Henry KC, Sherman PM. Vitamin D deficiency promotes epithelial barrier dysfunction and intestinal inflammation. J Infect Dis. 2014;210:1296–1305.CrossRefPubMedGoogle Scholar
  14. 14.
    van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol. 2005;97:93–101.CrossRefPubMedGoogle Scholar
  15. 15.
    Ulitsky A, Ananthakrishnan AN, Naik A, et al. Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. JPEN J Parenter Enteral Nutr. 2011;35:308–316.CrossRefPubMedGoogle Scholar
  16. 16.
    Thia K, Faubion WA Jr, Loftus EV Jr, Persson T, Persson A, Sandborn WJ. Short CDAI: development and validation of a shortened and simplified Crohn’s disease activity index. Inflamm Bowel Dis. 2011;17:105–111.CrossRefPubMedGoogle Scholar
  17. 17.
    Walmsley RS, Ayres RC, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut. 1998;43:29–32.PubMedCentralCrossRefPubMedGoogle Scholar
  18. 18.
    Casellas F, Alcala MJ, Prieto L, Miro JR, Malagelada JR. Assessment of the influence of disease activity on the quality of life of patients with inflammatory bowel disease using a short questionnaire. Am J Gastroenterol. 2004;99:457–461.CrossRefPubMedGoogle Scholar
  19. 19.
    Gholamrezaei A, Haghdani S, Shemshaki H, Tavakoli H, Emami MH. Linguistic validation of the Inflammatory Bowel Disease Questionnaire-Short Form (IBDQ-9) in Iranian population. J Isfahan Med Sch. 2011;28:1850–1859.Google Scholar
  20. 20.
    Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911–1930.CrossRefPubMedGoogle Scholar
  21. 21.
    Falvey JD, Hoskin T, Meijer B, et al. Disease activity assessment in IBD: clinical indices and biomarkers fail to predict endoscopic remission. Inflamm Bowel Dis. 2015;21:824–831.CrossRefPubMedGoogle Scholar
  22. 22.
    Vermeire S, Van AG, Rutgeerts P. Laboratory markers in IBD: Useful, magic, or unnecessary toys? Gut. 2006;55:426–431.PubMedCentralCrossRefPubMedGoogle Scholar
  23. 23.
    Schoepfer AM, Beglinger C, Straumann A, et al. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn’s disease (SES-CD) than CRP, blood leukocytes, and the CDAI. Am J Gastroenterol. 2010;105:162–169.CrossRefPubMedGoogle Scholar
  24. 24.
    Schoepfer AM, Beglinger C, Straumann A, et al. Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes. Inflamm Bowel Dis. 2013;19:332–341.CrossRefPubMedGoogle Scholar
  25. 25.
    Garg M, Rosella O, Lubel JS, Gibson PR. Association of circulating vitamin D concentrations with intestinal but not systemic inflammation in inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:2634–2643.CrossRefPubMedGoogle Scholar
  26. 26.
    Raftery T, Merrick M, Healy M, et al. Vitamin D status is associated with intestinal inflammation as measured by fecal calprotectin in Crohn’s disease in clinical remission. Dig Dis Sci. (Epub ahead of print). doi: 10.1007/s10620-015-3620-1.
  27. 27.
    Xue LN, Xu KQ, Zhang W, Wang Q, Wu J, Wang XY. Associations between vitamin D receptor polymorphisms and susceptibility to ulcerative colitis and Crohn’s disease: a meta-analysis. Inflamm Bowel Dis. 2013;19:54–60.CrossRefPubMedGoogle Scholar
  28. 28.
    Naderi N, Farnood A, Habibi M, et al. Association of vitamin D receptor gene polymorphisms in Iranian patients with inflammatory bowel disease. J Gastroenterol Hepatol. 2008;23:1816–1822.CrossRefPubMedGoogle Scholar
  29. 29.
    Ananthakrishnan AN, Khalili H, Higuchi LM, et al. Higher predicted vitamin D status is associated with reduced risk of Crohn’s disease. Gastroenterology. 2012;142:482–489.PubMedCentralCrossRefPubMedGoogle Scholar
  30. 30.
    Logan I, Bowlus CL. The geoepidemiology of autoimmune intestinal diseases. Autoimmun Rev. 2010;9:A372–A378.CrossRefPubMedGoogle Scholar
  31. 31.
    Nerich V, Jantchou P, Boutron-Ruault MC, et al. Low exposure to sunlight is a risk factor for Crohn’s disease. Aliment Pharmacol Ther. 2011;33:940–945.CrossRefPubMedGoogle Scholar
  32. 32.
    Jussila A, Virta LJ, Salomaa V, Maki J, Jula A, Farkkila MA. High and increasing prevalence of inflammatory bowel disease in Finland with a clear North-South difference. J Crohns Colitis. 2013;7:e256–e262.CrossRefPubMedGoogle Scholar
  33. 33.
    Limketkai BN, Bayless TM, Brant SR, Hutfless SM. Lower regional and temporal ultraviolet exposure is associated with increased rates and severity of inflammatory bowel disease hospitalisation. Aliment Pharmacol Ther. 2014;40:508–517.CrossRefPubMedGoogle Scholar
  34. 34.
    Sonnenberg A. Seasonal variation of enteric infections and inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:955–959.CrossRefPubMedGoogle Scholar
  35. 35.
    Blanck S, Aberra F. Vitamin d deficiency is associated with ulcerative colitis disease activity. Dig Dis Sci. 2013;58:1698–1702.CrossRefPubMedGoogle Scholar
  36. 36.
    Jorgensen SP, Hvas CL, Agnholt J, Christensen LA, Heickendorff L, Dahlerup JF. Active Crohn’s disease is associated with low vitamin D levels. J Crohns Colitis. 2013;7:e407–e413.CrossRefPubMedGoogle Scholar
  37. 37.
    Ham M, Longhi MS, Lahiff C, Cheifetz A, Robson S, Moss AC. Vitamin D levels in adults with Crohn’s disease are responsive to disease activity and treatment. Inflamm Bowel Dis. 2014;20:856–860.PubMedCentralCrossRefPubMedGoogle Scholar
  38. 38.
    El-Matary W, Sikora S, Spady D. Bone mineral density, vitamin D, and disease activity in children newly diagnosed with inflammatory bowel disease. Dig Dis Sci. 2011;56:825–829.CrossRefPubMedGoogle Scholar
  39. 39.
    Levin AD, Wadhera V, Leach ST, et al. Vitamin D deficiency in children with inflammatory bowel disease. Dig Dis Sci. 2011;56:830–836.CrossRefPubMedGoogle Scholar
  40. 40.
    Dumitrescu G, Mihai C, Dranga M, Prelipcean CC. Serum 25-hydroxyvitamin D concentration and inflammatory bowel disease characteristics in Romania. World J Gastroenterol. 2014;20:2392–2396.PubMedCentralCrossRefPubMedGoogle Scholar
  41. 41.
    Ananthakrishnan AN, Cagan A, Gainer VS, et al. Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn’s disease. Inflamm Bowel Dis. 2013;19:1921–1927.PubMedCentralPubMedGoogle Scholar
  42. 42.
    Hlavaty T, Krajcovicova A, Koller T, et al. Higher vitamin D serum concentration increases health related quality of life in patients with inflammatory bowel diseases. World J Gastroenterol. 2014;20:15787–15796.PubMedCentralCrossRefPubMedGoogle Scholar
  43. 43.
    Jorgensen SP, Agnholt J, Glerup H, et al. Clinical trial: vitamin D3 treatment in Crohn’s disease—a randomized double-blind placebo-controlled study. Aliment Pharmacol Ther. 2010;32:377–383.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Mehdi Torki
    • 1
    • 2
  • Ali Gholamrezaei
    • 2
    • 3
    Email author
  • Leila Mirbagher
    • 3
  • Manijeh Danesh
    • 3
  • Sara Kheiri
    • 3
  • Mohammad Hassan Emami
    • 1
    • 2
  1. 1.Department of Internal MedicineIsfahan University of Medical SciencesIsfahanIran
  2. 2.Poursina Hakim Research InstituteIsfahanIran
  3. 3.Medical Students’ Research CenterIsfahan University of Medical SciencesIsfahanIran

Personalised recommendations